Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.

Area of Science:

• Hemostasis and Thrombosis
• Molecular Mechanisms of Coagulation
• Vascular Biology

Background:

• Altered levels of coagulation factors (e.g., Factor VIII, prothrombin, antithrombin) are linked to venous thromboembolism (VTE) risk.
• The precise molecular mechanisms underlying this association remain incompletely understood.
• A hypothesis suggests that altered factor levels shift the pro- and anticoagulant balance, predisposing individuals to VTE.

Purpose of the Study:

• To investigate the role of tissue factor (TF) threshold in VTE risk.
• To test the hypothesis that elevated factor levels modulate thrombin generation initiation.
• To elucidate the impact of varying pro- and anticoagulant protein concentrations on TF-mediated thrombin formation.

Main Methods:

• Monitoring thrombin generation initiated by low TF concentrations in FXII-deficient plasma.
• Eliminating contact pathway activation to isolate TF-initiated thrombin formation.
• Assessing the effects of increasing concentrations of procoagulant and anticoagulant proteins.

Main Results:

• A variable TF-threshold for thrombin generation was established in FXII-deficient plasma.
• Elevated levels of procoagulant factors (FVIII, prothrombin) reduced the TF threshold, enhancing thrombin generation.
• Increased antithrombin levels raised the TF threshold, indicating a protective effect.

Conclusions:

• Findings support a mediating role of the TF-threshold in VTE risk associated with high procoagulant factor levels.
• Elevated levels of anticoagulants, such as antithrombin, may confer a protective effect against VTE development.